Article
An HIV Vaccine Protective Allele in FCGR2C Associates With Increased Odds of Perinatal HIV Acquisition.
Frontiers in immunology - 1 Jan 2021
Ebonwu Joy, Lassaunière Ria, Paximadis Maria, Goosen Mark, Strehlau Renate, Gray Glenda E, Kuhn Louise, Tiemessen Caroline T
Abstract excerpt
In the Thai RV144 HIV-1 vaccine trial, a three-variant haplotype within the Fc gamma receptor 2C gene (FCGR2C) reduced the risk of HIV-1 acquisition. A follow-on trial, HVTN702, of a similar vaccine candidate found no efficacy in South Africa, where the predominant population is polymorphic for only a single variant in the haplotype, c.134-96C>T (rs114945036). To investigate a role for this variant in HIV-1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
